mRNA |
Camptothecin |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.002 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.002 |
mRNA |
thapsigargin |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.002 |
mRNA |
Crizotinib |
GDSC1000 |
pan-cancer |
AAC |
0.18 |
0.002 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
Bosutinib |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.002 |
mRNA |
BRD-K71935468 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.003 |
mRNA |
CEP-701 |
GDSC1000 |
pan-cancer |
AAC |
-0.1 |
0.003 |
mRNA |
FH535 |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.004 |
mRNA |
BAY 61-3606 |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.004 |